China's state-backed funds are pulling back from investing in the funds of U.S.-headquartered private capital firms amid an ...

Private Equity business in Goldman Sachs Alternatives acquires majority stake in company ...

This is a second major private equity buyout deal of a SaaS firm this year, after Singapore-based private equity firm ...

Green Eyes is a founder-owned lab technology company that specializes in real-time, field-based nutrient analysis.

The market for leveraged buyouts showed signs of recovery this morning as Goldman Sachs launched a $4.5 billion debt deal ...

Goldman Sachs Alternatives has unveiled its latest private equity fund, G-PE, as part of its ‘G-Series’ suite of open-ended private markets funds. The launch is a significant step toward ...

"The announcement on our January earnings call of the intention to sell part of our stake in the business has generated ...

Goldman Sachs joins rivals JPMorgan Chase and Morgan Stanley in posting better-than-expected equities trading revenue.

The private equity business of Goldman Sachs Alternatives has acquired a majority stake in Gurgaon-based PeopleStrong, a technology-led human resources services provider, from Renuka Ramnath-led ...

Goldman Sachs Group Inc. is expanding its private equity offering to wealthy individuals across Wall Street and beyond, in the latest sign of investment firms gradually broadening access to the ...

CEO David Solomon highlighted strong financial performance in Q1 2025, with net revenues of $15.1 billion and earnings per share of $14.12. Return on equity was 16.9%, and return on tangible equity ...

Investindustrial has agreed to acquire DCC Healthcare from DCC at a total enterprise value of £1.1 billion ($1.4 billion; ...